Moreover, GDNF stimulates the formation of new axon terminals in dopamine neurons, which has led to an increased interest in the therapeutic potential of GDNF for the management of Parkinson’s disease (Bourque and Trudeau, 2000). This evidence concerns the gene GDNF and Parkinson disease.